Posted by Michael Wonder on 10 Jun 2026
Nipocalimab (Imaavy) authorised to treat adults and adolescents with generalised myasthenia gravis
9 June 2026 - The MHRA has today authorised the medicine nipocalimab (Imaavy) to treat adults and adolescents aged 12 years and older with generalised myasthenia gravis.
This application was approved under the International Recognition procedure.
